• Medicare, Medicaid, private insurance and other health care policies that impact patient access to cardiovascular care, including H.R. 1010, the "ENROLL Act (H.R. 1386)", the "State Health Care Premium Reduction Act of 2019 (H.R. 1425)", the "Protecting Americans with Pre-Existing Conditions Act of 2019 (H.R. 466)", the "Educating Consumers on the Risk of Short Term Plans Act of 2019 (H.R. 1143)", the "Strengthening Health Care and Lowering Prescription Drug Costs Act (S. 987)", the "Lowering Health Care Costs Act (S. 1895)", the "No Surprises Act (H.R. 3630)" and "Increasing Access to Quality Rehabilitation Care Act of 2019 (H.R. 3911, S.2842)", the "Coronavirus Preparedness and Response Supplemental (H.R. 6074)", the "Families First Coronavirus Response Act (H.R. 6201)", the "Coronavirus Aid, Relief and Economic Security Act (H.R. 748)", the "Ban Surprise Billing Act (H.R. 5800)" the "Consumer Protections Against Surprise Medical Bills Act (H.R. 5826)", the "Health and Economic Recovery Omnibus Emergency Solutions Act (H.R. 6800)", and the "Paycheck Protection Program and Health Care Enhancement Act (H.R. 266)".

Duration: February 1, 2015 to June 30, 2020

General Issues: Health Issues

Spending: about $172,300 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2015: U.S. Senate, House of Representatives